Recognition of Members for Research Contributions, New Initiatives, and Achievements
-
By
-
RC Central Editorial Team
-
May 4, 2026
By
RC Central Editorial Team
May 4, 2026
Head and neck abscess incidence was more than 3-fold higher following the pandemic, while patient characteristics and treatment patterns remained largely similar.
September 11, 2026
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026